somatropin
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Infant, Small for Gestational Age
Conditions
Infant, Small for Gestational Age
Trial Timeline
Dec 1, 2002 → Jun 1, 2007
NCT ID
NCT00191529About somatropin
somatropin is a phase 3 stage product being developed by Eli Lilly for Infant, Small for Gestational Age. The current trial status is completed. This product is registered under clinical trial identifier NCT00191529. Target conditions include Infant, Small for Gestational Age.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00191360 | Phase 3 | Completed |
| NCT00191529 | Phase 3 | Completed |
| NCT00406926 | Phase 3 | Completed |
| NCT00490191 | Approved | Completed |
Competing Products
20 competing products in Infant, Small for Gestational Age
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| TSHA-101 | Taysha Gene Therapies | Phase 1/2 | 36 |
| Placebo + Cisapride | Johnson & Johnson | Approved | 85 |
| RotaTeq (V260) + IPV | Merck | Phase 3 | 77 |
| recombinant somatropin | Merck | Pre-clinical | 23 |
| Recombinant human growth hormone (r-hGH) | Merck | Phase 3 | 77 |
| MAS825 + Placebo | Novartis | Phase 2 | 52 |
| epoetin beta + epoetin beta | Roche | Pre-clinical | 23 |
| Genotropin (PN-180,307) Somatropin + Control-no treatment | Pfizer | Phase 3 | 76 |
| Prevenar (13v) | Pfizer | Pre-clinical | 22 |
| rhBSSL + Placebo | Swedish Orphan Biovitrum | Phase 2 | 51 |
| rhBSSL + Placebo | Swedish Orphan Biovitrum | Phase 2 | 51 |
| DT5aP-IPV-Hib 5-component Pertussis vaccine + DT3aP-HBs-IPV | Sanofi | Phase 3 | 76 |
| alglucosidase alfa + alglucosidase alfa | Sanofi | Approved | 84 |
| Myozyme | Sanofi | Phase 2 | 51 |
| Bacillus Clausii Multi ATB Resist + Placebo | Sanofi | Approved | 84 |
| Radiprodil | UCB | Phase 2 | 49 |
| Larotrectinib (Vitrakvi, BAY2757556) + Standard of Care | Bayer | Pre-clinical | 20 |
| Sabril® | Lundbeck | Pre-clinical | 20 |
| Vigabatrin | Lundbeck | Approved | 82 |
| Nusinersen | Biogen | Pre-clinical | 20 |